The Value of Budget Impact Analyses in Evaluating Targeted Therapies—The Case of RSV Prophylaxis for Preterm Infants

Value in Health - United Kingdom
doi 10.1016/j.jval.2010.10.001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pmu29 - Evaluating Budget Impact Analyses for Extramural Drugs in the Netherlands

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Hospitalisation for RSV Infection in Ex-Preterm Infants---Implications for Use of RSV Immune Globulin

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2000English

Indomethacin Prophylaxis for Preterm Infants: The Impact of 2 Multicentered Randomized Controlled Trials on Clinical Practice

Journal of Pediatrics
Child HealthPediatricsPerinatology
2007English

Oligosaccharides in Human Milk and in Milk Formulas for Preterm Infants – Value for Preterm Infants

Neonatology, surgery and perinatal medicine
2019English

Perioperative Antibiotic Prophylaxis: Budget Impact Analysis

Vestnik of Saint Petersburg University. Medicine
2018English

P82 Comparison of RSV Hospitalisation in Preterm Infants With Chronic Lung Disease Who Do Not Qualify for Palivizumab Prophylaxis With Those Who Qualify in Nottingham, Uk

2017English

Targeted Early Rescue Surfactant in Ventilated Preterm Infants Using the Click Test

Pediatrics
Child HealthPediatricsPerinatology
2000English

Emerging Targeted Therapies for Plaque Psoriasis &Ndash; Impact of Ixekizumab

Clinical, Cosmetic and Investigational Dermatology
Dermatology
2017English

Impact of Maternal Obesity on Very Preterm Infants

Obesity
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy